Causal Involvement of Immune Cells in Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s460342 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Tiefa Guan und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, People's Republic of China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Mendelian Randomization Analysis, Genome-Wide Association Study, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Seedling project of the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.
Themen: COPD
Abstract (Originalsprache)
Background
The immune cells play a substantial role in the development and progression of chronic obstructive pulmonary disease (COPD). We aim to investigate the causal involvement of immune cells in COPD via a Mendelian randomization (MR) analysis.
Methods
Published genome-wide association studies (GWAS) statistics on immune cells were analyzed, with genetic variants identified as instrumental variables (IVs). Inverse-variance weighting (IVW), weighted median, and MR-Egger regression methods were employed, along with simple mode and weighted mode adopted in the two-sample MR analysis. Sensitivity analysis was conducted to examine the heterogeneity, horizontal pleiotropy, and stability of the causal relationship.
Results
IVW results suggested that CCR2 on CD62L+ plasmacytoid dendritic cells (DC), CCR2 on plasmacytoid DC, CD11b on CD66b++ myeloid cells, CD19 on CD20- CD38- CD24+ memory B cell subset, CD25 on transitional B cells, and CD25++CD8br %CD8br T cells were risk factors for the development of COPD. Besides, CD127 on effector memory-like cytotoxic T lymphocytes lacking expression of co-stimulatory molecule 28 (CD28-EM CTLs) and HLA DR+ NK ACs expressing human leukocyte antigen DR molecules while being natural killer cells (%NK ACs) were protective factors for COPD.
Conclusion
This study unveiled a causal relationship between immune cell phenotype and COPD. These findings offer new insights for the prevention and treatment of COPD using COPD-associated immune cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, People's Republic of China.
ORCID-Profile: Tiefa Guan
Förderung
- National Natural Science Foundation of China
- Seedling project of the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Zitieren
APA
Guan, T., Qin, Y., Qu, N., & Pan, Y. (2024). Causal Involvement of Immune Cells in Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s460342
Vancouver
Guan T, Qin Y, Qu N, Pan Y. Causal Involvement of Immune Cells in Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s460342
BibTeX
@article{Guan2024,
author = {Guan, Tiefa and Qin, Yibing and Qu, Nini and Pan, Yushuo},
title = {Causal Involvement of Immune Cells in Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s460342}
}
EUVIMED